MDA-19 N-(5-hydroxyhexyl) is a cannabinoid receptor modulator that targets CB1R/CB2R. It is applicable in research related to neurological disorders, cancer, and pain regulation.
Target:
Cannabinoid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted